Annual Retained Earnings
-$54.24 M
-$22.26 M-69.60%
December 31, 2023
Summary
- As of February 7, 2025, NVCT annual retained earnings is -$54.24 million, with the most recent change of -$22.26 million (-69.60%) on December 31, 2023.
- During the last 3 years, NVCT annual retained earnings has fallen by -$54.23 million (-542350.00%).
- NVCT annual retained earnings is now -542350.00% below its all-time high of -$10.00 thousand, reached on December 31, 2020.
Performance
NVCT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$67.00 M
-$4.15 M-6.61%
September 30, 2024
Summary
- As of February 7, 2025, NVCT quarterly retained earnings is -$67.00 million, with the most recent change of -$4.15 million (-6.61%) on September 30, 2024.
- Over the past year, NVCT quarterly retained earnings has dropped by -$19.37 million (-40.68%).
- NVCT quarterly retained earnings is now -1022.04% below its all-time high of -$5.97 million, reached on June 30, 2021.
Performance
NVCT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NVCT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.6% | -40.7% |
| 3 y3 years | -10000.0% | -40.7% |
| 5 y5 years | -10000.0% | -40.7% |
NVCT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -320.5% | at low | -419.4% | at low |
| 5 y | 5-year | <-9999.0% | at low | -1022.0% | at low |
| alltime | all time | <-9999.0% | at low | -1022.0% | at low |
Nuvectis Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$67.00 M(+6.6%) |
| Jun 2024 | - | -$62.84 M(+7.6%) |
| Mar 2024 | - | -$58.42 M(+7.7%) |
| Dec 2023 | -$54.24 M(+69.6%) | -$54.24 M(+13.9%) |
| Sep 2023 | - | -$47.62 M(+14.1%) |
| Jun 2023 | - | -$41.74 M(+15.8%) |
| Mar 2023 | - | -$36.03 M(+12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$31.98 M(+147.9%) | -$31.98 M(+26.5%) |
| Sep 2022 | - | -$25.29 M(+30.3%) |
| Jun 2022 | - | -$19.41 M(+22.5%) |
| Mar 2022 | - | -$15.84 M(+22.8%) |
| Dec 2021 | -$12.90 M(>+9900.0%) | -$12.90 M(+21.3%) |
| Sep 2021 | - | -$10.64 M(+78.2%) |
| Jun 2021 | - | -$5.97 M |
| Dec 2020 | -$10.00 K | - |
FAQ
- What is Nuvectis Pharma annual retained earnings?
- What is the all time high annual retained earnings for Nuvectis Pharma?
- What is Nuvectis Pharma annual retained earnings year-on-year change?
- What is Nuvectis Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly retained earnings year-on-year change?
What is Nuvectis Pharma annual retained earnings?
The current annual retained earnings of NVCT is -$54.24 M
What is the all time high annual retained earnings for Nuvectis Pharma?
Nuvectis Pharma all-time high annual retained earnings is -$10.00 K
What is Nuvectis Pharma annual retained earnings year-on-year change?
Over the past year, NVCT annual retained earnings has changed by -$22.26 M (-69.60%)
What is Nuvectis Pharma quarterly retained earnings?
The current quarterly retained earnings of NVCT is -$67.00 M
What is the all time high quarterly retained earnings for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly retained earnings is -$5.97 M
What is Nuvectis Pharma quarterly retained earnings year-on-year change?
Over the past year, NVCT quarterly retained earnings has changed by -$19.37 M (-40.68%)